Biocon Foundation with NCBS & BeST Cluster launches BioWISE Programme to empower women in STEM: Our Bureau, Bengaluru Monday, ...

DHN unveils landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI emerges as top priority: Our ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Alcon introduces PRECISION1, next-generation daily disposable contact lenses, in India: Our Bureau, Mumbai Monday, June 9, ...

New artificial intelligence-powered service launched to transform cancer detection and care: United Kingdom Monday, June 9, 2025, 13:00 Hrs [IST] A new artificial intelligence (AI ...

Lupin receives US FDA tentative approval for oxcarbazepine ER tablets: Our Bureau, Mumbai Monday, June 9, 2025, 11:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...

Phio Pharma announces strategic initiative to create awareness of the comprehensive INTASYL siRNA portfolio: Marlborough, Massachusetts Monday, June 9, 2025, 12:00 Hrs [IST] Phio ...

Telix’s Illuccix PSMA-PET imaging agent receives German approval: Melbourne, Australia Monday, June 9, 2025, 14:00 Hrs [IST] Telix announces that its prostate cancer PET imaging ...

US FDA clears YolTech’s IND application for YOLT-101, an in vivo base editing therapy to treat heterozygous familial hypercholesterolemia: Shanghai, China Monday, June 9, 2025, ...

CDSCO’s guidance document specifies disposal methods of expired & unused drugs: Gireesh Babu, New Delhi Monday, June 9, 2025, ...

Mediar Therapeutics doses first patient in phase 2 WISPer trial of MTX-463 for idiopathic pulmonary fibrosis: Boston Monday, June 9, 2025, 15:00 Hrs [IST] Mediar Therapeutics, Inc ...

EMA’s safety committee concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus & Wegovy: Amsterdam, The Netherlands Monday, June 9, 2 ...